MARISSA NAVARROLI: Open Payments
NPI 1821507765 · PROVIDENCE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$468 in 18 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $198 · 2025 $468
Food & beverage: $468
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 1 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $47 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| Lilly USA, LLC | 2 | $45 |
| ABBVIE INC. | 2 | $43 |
| Amgen Inc. | 2 | $40 |
| Alexion Pharmaceuticals, Inc. | 1 | $28 |
| Organon LLC | 1 | $24 |
| Eisai Inc. | 1 | $24 |
Products named: SPRAVATO, LEQVIO, OMVOH, SKYRIZI, KRYSTEXXA, FASENRA, ULTOMIRIS, HADLIMA.
Industry payments across RI — which companies pay providers there.
